vs
Amentum Holdings, Inc.（AMTM）与费森尤斯医疗（FMS）财务数据对比。点击上方公司名可切换其他公司
费森尤斯医疗的季度营收约是Amentum Holdings, Inc.的1.7倍（$5.5B vs $3.2B），费森尤斯医疗净利率更高（7.9% vs 1.4%，领先6.6%），费森尤斯医疗同比增速更快（-0.3% vs -5.2%）
本公司是总部位于美国达拉斯的跨国技术专业服务企业，面向全球企业、机构及政府部门客户提供工程、技术、建设服务以及科学与专项咨询服务，连续6年蝉联《工程新闻纪录》（ENR）全球顶尖设计企业500强榜首。
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
AMTM vs FMS — 直观对比
营收规模更大
FMS
是对方的1.7倍
$3.2B
营收增速更快
FMS
高出4.9%
-5.2%
净利率更高
FMS
高出6.6%
1.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.2B | $5.5B |
| 净利润 | $44.0M | $434.2M |
| 毛利率 | 10.1% | 27.4% |
| 营业利润率 | 4.3% | 11.7% |
| 净利率 | 1.4% | 7.9% |
| 营收同比 | -5.2% | -0.3% |
| 净利润同比 | 266.7% | 240.4% |
| 每股收益（稀释后） | $0.18 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMTMFMS
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.9B | $5.5B | ||
| Q2 25 | $3.6B | — | ||
| Q1 25 | $3.5B | — | ||
| Q4 24 | $3.4B | $5.5B | ||
| Q3 24 | $2.2B | — | ||
| Q2 24 | $2.1B | — | ||
| Q1 24 | $2.1B | — |
净利润AMTMFMS
| Q1 26 | $44.0M | — | ||
| Q4 25 | $40.0M | $434.2M | ||
| Q2 25 | $10.0M | — | ||
| Q1 25 | $4.0M | — | ||
| Q4 24 | $12.0M | $127.6M | ||
| Q3 24 | $26.0M | — | ||
| Q2 24 | $-26.0M | — | ||
| Q1 24 | $-41.0M | — |
毛利率AMTMFMS
| Q1 26 | 10.1% | — | ||
| Q4 25 | 10.6% | 27.4% | ||
| Q2 25 | 10.3% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 10.6% | 25.0% | ||
| Q3 24 | 9.0% | — | ||
| Q2 24 | 9.6% | — | ||
| Q1 24 | 9.8% | — |
营业利润率AMTMFMS
| Q1 26 | 4.3% | — | ||
| Q4 25 | 3.4% | 11.7% | ||
| Q2 25 | 2.9% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 3.9% | 5.1% | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 4.3% | — |
净利率AMTMFMS
| Q1 26 | 1.4% | — | ||
| Q4 25 | 1.0% | 7.9% | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.4% | 2.3% | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | -1.2% | — | ||
| Q1 24 | -2.0% | — |
每股收益（稀释后）AMTMFMS
| Q1 26 | $0.18 | — | ||
| Q4 25 | $0.16 | — | ||
| Q2 25 | $0.04 | — | ||
| Q1 25 | $0.02 | — | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.31 | — | ||
| Q2 24 | $-0.29 | — | ||
| Q1 24 | $-0.46 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $247.0M | $1.7B |
| 总债务越低越好 | $3.9B | — |
| 股东权益账面价值 | $4.6B | $15.4B |
| 总资产 | $11.2B | $33.5B |
| 负债/权益比越低杠杆越低 | 0.86× | — |
8季度趋势，按日历期对齐
现金及短期投资AMTMFMS
| Q1 26 | $247.0M | — | ||
| Q4 25 | $437.0M | $1.7B | ||
| Q2 25 | $738.0M | — | ||
| Q1 25 | $546.0M | — | ||
| Q4 24 | $522.0M | $1.3B | ||
| Q3 24 | $452.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
总债务AMTMFMS
| Q1 26 | $3.9B | — | ||
| Q4 25 | $3.9B | — | ||
| Q2 25 | $4.5B | — | ||
| Q1 25 | $4.7B | — | ||
| Q4 24 | $4.7B | — | ||
| Q3 24 | $4.7B | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AMTMFMS
| Q1 26 | $4.6B | — | ||
| Q4 25 | $4.5B | $15.4B | ||
| Q2 25 | $4.5B | — | ||
| Q1 25 | $4.4B | — | ||
| Q4 24 | $4.5B | $17.0B | ||
| Q3 24 | $4.5B | — | ||
| Q2 24 | $303.0M | — | ||
| Q1 24 | $324.0M | — |
总资产AMTMFMS
| Q1 26 | $11.2B | — | ||
| Q4 25 | $11.5B | $33.5B | ||
| Q2 25 | $11.8B | — | ||
| Q1 25 | $12.0B | — | ||
| Q4 24 | $11.9B | $36.3B | ||
| Q3 24 | $12.0B | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
负债/权益比AMTMFMS
| Q1 26 | 0.86× | — | ||
| Q4 25 | 0.88× | — | ||
| Q2 25 | 1.01× | — | ||
| Q1 25 | 1.06× | — | ||
| Q4 24 | 1.05× | — | ||
| Q3 24 | 1.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-136.0M | $2.9B |
| 自由现金流经营现金流 - 资本支出 | $-142.0M | — |
| 自由现金流率自由现金流/营收 | -4.4% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | -3.09× | 6.67× |
| 过去12个月自由现金流最近4个季度 | $272.0M | — |
8季度趋势，按日历期对齐
经营现金流AMTMFMS
| Q1 26 | $-136.0M | — | ||
| Q4 25 | $270.0M | $2.9B | ||
| Q2 25 | $106.0M | — | ||
| Q1 25 | $57.0M | — | ||
| Q4 24 | $110.0M | $2.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流AMTMFMS
| Q1 26 | $-142.0M | — | ||
| Q4 25 | $261.0M | — | ||
| Q2 25 | $100.0M | — | ||
| Q1 25 | $53.0M | — | ||
| Q4 24 | $102.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率AMTMFMS
| Q1 26 | -4.4% | — | ||
| Q4 25 | 6.6% | — | ||
| Q2 25 | 2.8% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度AMTMFMS
| Q1 26 | 0.2% | — | ||
| Q4 25 | 0.2% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率AMTMFMS
| Q1 26 | -3.09× | — | ||
| Q4 25 | 6.75× | 6.67× | ||
| Q2 25 | 10.60× | — | ||
| Q1 25 | 14.25× | — | ||
| Q4 24 | 9.17× | 20.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMTM
| Global Engineering Solutions Segment | $1.9B | 59% |
| Other U.S.Government Agencies | $400.0M | 12% |
| Fixed Price Contract | $380.0M | 12% |
| Commercial And International | $226.0M | 7% |
| Time And Materials Contract | $171.0M | 5% |
| Sales Channel Through Intermediary | $78.0M | 2% |
| Equity Method Investee | $50.0M | 2% |
FMS
暂无分部数据
